Recurrent skin reaction secondary to darbepoetin alfa for two months in a patient with chronic lymphocytic leukemia.
Jabr
Fadi I
FI
Taher
Ali
A
D000368:Aged; D000068256:Darbepoetin alfa; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D012008:Recurrence; D016896:Treatment Outcome
D004921:Erythropoietin; D000068256:Darbepoetin alfa